893 related articles for article (PubMed ID: 11142574)
1. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
[TBL] [Abstract][Full Text] [Related]
2. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
[TBL] [Abstract][Full Text] [Related]
4. A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori.
Laine L; Frantz JE; Baker A; Neil GA
Aliment Pharmacol Ther; 1997 Oct; 11(5):913-7. PubMed ID: 9354200
[TBL] [Abstract][Full Text] [Related]
5. The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori.
Pilotto A; Leandro G; Franceschi M; Rassu M; Bozzola L; Furlan F; Di Mario F; Valerio G
Aliment Pharmacol Ther; 1999 May; 13(5):667-73. PubMed ID: 10233191
[TBL] [Abstract][Full Text] [Related]
6. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
Sung JJ; Chan FK; Wu JC; Leung WK; Suen R; Ling TK; Lee YT; Cheng AF; Chung SC
Aliment Pharmacol Ther; 1999 Aug; 13(8):1079-84. PubMed ID: 10468684
[TBL] [Abstract][Full Text] [Related]
7. Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group.
Wurzer H; Rodrigo L; Stamler D; Archambault A; Rokkas T; Skandalis N; Fedorak R; Bazzoli F; Hentschel E; Mora P; Archimandritis A; Megraud F
Aliment Pharmacol Ther; 1997 Oct; 11(5):943-52. PubMed ID: 9354205
[TBL] [Abstract][Full Text] [Related]
8. The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection.
Bardhan K; Bayerdörffer E; Veldhuyzen Van Zanten SJ; Lind T; Mégraud F; Delchier JC; Hellblom M; Stubberöd A; Burman CF; Gromark P; Zeijlon L
Helicobacter; 2000 Dec; 5(4):196-201. PubMed ID: 11179983
[TBL] [Abstract][Full Text] [Related]
9. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
10. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
11. One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection.
Labenz J; Stolte M; Peitz U; Tillenburg B; Becker T; Börsch G
Aliment Pharmacol Ther; 1996 Apr; 10(2):207-10. PubMed ID: 8730252
[TBL] [Abstract][Full Text] [Related]
12. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
Ahuja V; Dhar A; Bal C; Sharma MP
Aliment Pharmacol Ther; 1998 Jun; 12(6):551-5. PubMed ID: 9678815
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
[TBL] [Abstract][Full Text] [Related]
14. One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy.
Sheu BS; Wu JJ; Yang HB; Huang AH; Lin XZ
J Formos Med Assoc; 1998 Apr; 97(4):266-70. PubMed ID: 9585678
[TBL] [Abstract][Full Text] [Related]
15. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
16. Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection.
Miehlke S; Meining A; Lehn N; Höchter W; Weingart J; Simon T; Krämer W; Klann H; Bolle K; Sommer A; Stolte M; Bayerdörffer E
Digestion; 1998; 59(6):646-50. PubMed ID: 9813387
[TBL] [Abstract][Full Text] [Related]
17. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
[TBL] [Abstract][Full Text] [Related]
18. Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.
Bardhan KD; Dillon J; Axon AT; Cooper BT; Tildesley G; Wyatt JI; Gatz G; Braun W
Aliment Pharmacol Ther; 2000 Jan; 14(1):59-67. PubMed ID: 10632646
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains.
Houben MH; Hensen EF; Rauws EA; Hulst RW; Hoff BW; Ende AV; Kate FJ; Tytgat GN
Aliment Pharmacol Ther; 1999 Jul; 13(7):883-9. PubMed ID: 10383522
[TBL] [Abstract][Full Text] [Related]
20. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
